NCT03309293

Brief Summary

the investigators hypothesize that some of these polymorphisms contribute to VTE risk in women using COC, and that their screening could to help assess individual risk of VTE before COC prescription. In order to test this hypothesis the investigators propose to build a predictive score for VTE in women using COC based on clinical and biological factors. To this end the investigators have a large case study (including 766 patients) recruited at the "Centre d'Exploration des Pathologies Hémorragiques et Thrombotiques" (CEHT) of the laboratory of Hematology (La Timone Hospital, Marseille) between 2003 and 2013. The cases had a personal history of documented VTE while using COC (PILGRIM study). A great number of clinical and biological relevant phenotypes in the field of VTE have already been collected (including 14 polymorphisms selected on the basis of their biological plausibility and the existence association studies).To our knowledge it is the largest study specifically conducted in order to assess genetic factors associated with VTE in women using COC. These 766 cases will be compared to 766 controls from the general population (cohort Nutrinet-Santé). Then, the predictive values of the score will be assessed in an independent multicentric validation study that the investigators will set up in the field of this project. Our study should allow a better understanding of the genetic and environmental factors involved in VTE related to COC use. Besides, this project aims to respond to a major public health issue giving an effective tool for the decision of prescribing COC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,454

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2017

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 5, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 13, 2017

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2023

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

6.8 years

First QC Date

October 5, 2017

Last Update Submit

June 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Build a predictive score for VTE in women using COC

    this score is based on clinical and biological factors

    42 months

Study Arms (2)

controls

OTHER

biological samples bank

Biological: blood samples

cases

EXPERIMENTAL
Biological: blood samples

Interventions

blood samplesBIOLOGICAL

blood samples

casescontrols

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women who had an episode of documented VTE (deep vein thrombosis and / or pulmonary embolism) under COC who consulted in a specialized counseling center.
  • Women of age.
  • Subject agreeing to participate in this research, having signed informed consent.

You may not qualify if:

  • Absence of COC,
  • No knowledge of the COC generation used by the patient,
  • Undocumented MTEV Episode
  • Absence of available sample (DNA),
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hopitaux de Marseille

Marseille, 13354, France

Location

MeSH Terms

Conditions

Venous Thromboembolism

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • jean-olivier ARNAUD

    Assistance Publique Hopitaux De Marseille

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2017

First Posted

October 13, 2017

Study Start

January 18, 2017

Primary Completion

November 9, 2023

Study Completion

November 9, 2023

Last Updated

June 27, 2025

Record last verified: 2025-06

Locations